Acute Flaccid Myelitis Surveillance - United States, January 2020-December 2025

Adriana S Lopez1, Randall English1, Shannon L Rogers1

  • 1National Center for Immunization and Respiratory Diseases, CDC.

Insights

Nationwide surveillance from 2020-2025 shows low acute flaccid myelitis (AFM) cases, despite enterovirus circulation. Polio vaccination did not prevent most AFM cases, highlighting the need for continued vigilance and reporting.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Public Health Surveillance

Background:

  • Acute flaccid myelitis (AFM) is a serious neurologic condition causing paralysis, particularly in children.
  • AFM is clinically and radiologically indistinguishable from poliovirus-induced acute flaccid paralysis.
  • Nationwide AFM surveillance in the U.S. began in 2014 due to a recognized increase in cases.

Purpose of the Study:

  • To provide an update on nationwide surveillance of confirmed AFM cases from January 2020 to December 2025.
  • To assess the association between enterovirus circulation, particularly EV-D68, and AFM case trends.
  • To evaluate the polio vaccination status of AFM patients and the role of surveillance in detecting other vaccine-preventable diseases.

Main Methods:

  • Analysis of nationwide surveillance data for confirmed AFM cases reported to the CDC.
  • Monitoring of enterovirus circulation, including EV-D68, through sentinel surveillance sites.
  • Review of clinical and laboratory data, including stool specimen testing and polio vaccination status.

Main Results:

  • Confirmed AFM cases remained low (17-48 annually) from 2020-2025, significantly lower than peaks in 2014, 2016, and 2018.
  • Despite seasonal enterovirus circulation and increased EV-D68 respiratory illnesses in 2022, 2024, and 2025, no concurrent increase in AFM cases was observed.
  • EV-D68 was detected in only one AFM patient specimen during the surveillance period; most AFM cases occurred in vaccinated individuals.
  • A polio case in an unvaccinated person was identified through AFM surveillance in 2022.

Conclusions:

  • Current nationwide surveillance indicates a low incidence of AFM despite ongoing enterovirus activity.
  • The majority of AFM cases occurred in individuals up-to-date with polio vaccination, suggesting other factors may be involved.
  • AFM surveillance remains crucial for detecting other serious conditions, including polio, emphasizing the importance of clinical reporting and sample collection.

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...